Pharmacists in Wagoner, OK Accepting Medicare
17 Pharmacists found. Showing 1 - 17
 Clinton King, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 410 S Dewey Ave, Wagoner, OK 74467 Phone: 918-485-4581 |
Ethan Garret Colwell Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1305 W Cherokee St, Wagoner, OK 74467 Phone: 918-485-6688 |
Jeremy Landsaw, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 1200 W Cherokee St, Wagoner, OK 74467 Phone: 918-485-1364 |
Steven Daniel Chase, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1214 W Cherokee St, Wagoner, OK 74467 Phone: 918-485-4502 Fax: 918-485-4041 |
 Dr. Sha Lynn Bigelow, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1305 W Cherokee St, Wagoner, OK 74467 Phone: 918-485-6688 Fax: 918-485-6684 |
Dr. Jason O'neal, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1305 W Cherokee St, Wagoner, OK 74467 Phone: 918-485-6688 |
Dr. Ronald Wayne Nicholas, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 326 E Cherokee St, Wagoner, OK 74467 Phone: 918-485-2317 Fax: 918-485-8483 |
Gerry Oquinn Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 72928 S 330 Rd, Wagoner, OK 74467 Phone: 918-485-9036 |
Jamiu Adekunle Oyedele, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1305 W Cherokee St, Wagoner, OK 74467 Phone: 918-485-6688 Fax: 918-485-6684 |
Molly Rachel Mcmanus, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 410 S Dewey Ave, Wagoner, OK 74467 Phone: 918-485-4581 Fax: 918-485-3163 |
Dr. Nathan Swisher, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1305 W Cherokee St, Wagoner, OK 74467 Phone: 918-485-6688 |
Dr. Omead Ghaeli, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1305 W Cherokee St, Wagoner, OK 74467 Phone: 918-485-4581 Fax: 918-485-3163 |
Dr. Stephen Paul Nicholas, D.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 326 E Cherokee St, Wagoner, OK 74467 Phone: 918-485-2317 Fax: 918-485-8493 |
Dr. Annette L Phelps, D.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1305 W Cherokee St, Wagoner, OK 74467 Phone: 918-485-6688 Fax: 918-485-6684 |
Dr. Phu Pham Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1305 W Cherokee St, Wagoner, OK 74467 Phone: 918-485-6688 |
Victoria Vo Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 410 S Dewey Ave, Wagoner, OK 74467 Phone: 918-485-4581 Fax: 918-485-3163 |
Kristy Lea Vowell, RPH, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 410 S Dewey Ave, Wagoner, OK 74467 Phone: 918-485-4581 |
News Archive
Arthritis causes more pain and limitations for African-Americans and Hispanics
Arthritis causes more pain and limitations for African-Americans and Hispanics than for whites, according to a study released today by the Centers for Disease Control and Prevention.
Scientists identify measures for reducing $2 billion healthcare burden from substance abuse
With substance abuse now accounting for one in 14 hospital admissions and generating billions in health care costs, leading scientists held a briefing on Capitol Hill today to present the evidence that we already have and the evidence we need in treating and preventing the use and abuse of alcohol, drugs and tobacco.
Eddingpharm plans to begin Phase 1 study for BRINAVESS in China
Cardiome Pharma Corp. today announced that its Chinese development and commercialization partner, Eddingpharm, plans to initiate a Phase 1 study for BRINAVESSTM to support regulatory approval in China. The study will be conducted in healthy volunteers.
Symic receives $1.5M NIH Phase II SBIR grant to develop AVF therapeutic candidate
Platform therapeutic company Symic Biomedical, Inc. announced today that it has received a $1.5M Phase II SBIR grant from the National Institutes of Health to further develop its therapeutic agent to reduce arteriovenous fistula (AVF) failures, a significant unmet clinical need in end stage renal disease (ESRD) patients undergoing hemodialysis.
› Verified 2 days ago
Counselors
Pharmacists
Dentists
Clinical Social Workers
Occupational Therapists